Achaogen Named One Of 2009 "Fierce 15" Biotechnology Companies
/"Achaogen has set its sights on developing a new generation of antibacterials. Its lead program has just finished a Phase I safety trial with positive results, government grants have poured in and a new venture round will keep the company well financed."
FierceBiotech